PSA (PSORIATIC ARTHRITIS)
Clinical trials for PSA (PSORIATIC ARTHRITIS) explained in plain language.
Never miss a new study
Get alerted when new PSA (PSORIATIC ARTHRITIS) trials appear
Sign up with your email to follow new studies for PSA (PSORIATIC ARTHRITIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug SPY002-072 aims to tame multiple inflammatory joint diseases
Disease control OngoingThis Phase 2 study tests an experimental drug called SPY002-072 in 285 adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis. Participants receive either the drug or a placebo, and researchers measure changes in disease ac…
Matched conditions: PSA (PSORIATIC ARTHRITIS)
Phase: PHASE2 • Sponsor: Spyre Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Fatty liver and psoriasis study pulled before it started
Knowledge-focused TerminatedThis study aimed to understand the link between non-alcoholic fatty liver disease (NAFLD) and psoriatic disease (psoriasis and psoriatic arthritis) in overweight adults. Researchers planned to use the drug guselkumab (Tremfya) to see if it improved both conditions. However, the t…
Matched conditions: PSA (PSORIATIC ARTHRITIS)
Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC